AAAAAA

   
Results: 1-13 |
Results: 13

Authors: GIANOTTI L FORTIS C BRAGA M GENTILINI O VIGNALI A DICARLO V
Citation: L. Gianotti et al., RADICAL ONCOLOGIC SURGERY AFFECTS THE CIRCULATORY LEVELS OF INTERLEUKIN-10, Journal of surgical oncology, 66(4), 1997, pp. 244-247

Authors: FORTIS C FOPPOLI M GIANOTTI L GALLI L CITTERIO G CONSOGNO G GENTILINI O BRAGA M
Citation: C. Fortis et al., INCREASED INTERLEUKIN-10 SERUM LEVELS IN PATIENTS WITH SOLID TUMORS, Cancer letters, 104(1), 1996, pp. 1-5

Authors: MAFFEZZINI M SIMONATO A FORTIS C
Citation: M. Maffezzini et al., SALVAGE IMMUNOTHERAPY WITH SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 (RIL-2) AND ALPHA-INTERFERON (A-IFN) FOR STAGE D3 PROSTATE CARCINOMA FAILING 2ND-LINE HORMONAL TREATMENT, The Prostate, 28(5), 1996, pp. 282-286

Authors: CAPELLI E BARNI S VACCARONE R FORTIS C NANO R
Citation: E. Capelli et al., CELL ACTIVATION AND DEATH (APOPTOSIS) INDUCED BY IL-2 - ULTRASTRUCTURAL EVIDENCE, Anticancer research, 16(4A), 1996, pp. 1775-1780

Authors: BRAGA M GIANOTTI L GENTILINI O FORTIS C CONSOGNO G DICARLO V
Citation: M. Braga et al., THYMOPENTIN MODULATES TH1 AND TH2 CYTOKINE RESPONSE AND HOST SURVIVALIN EXPERIMENTAL INJURY, The Journal of surgical research, 62(2), 1996, pp. 197-200

Authors: CITTERIO G PELLEGATTA F DILUCCA G FRAGASSO G SCAGLIETTI U PINI D FORTIS C TRESOLDI M RUGARLI C
Citation: G. Citterio et al., PLASMA NITRATE PLUS NITRITE CHANGES DURING CONTINUOUS INTRAVENOUS-INFUSION INTERLEUKIN-2, British Journal of Cancer, 74(8), 1996, pp. 1297-1301

Authors: FERRERO ME CORSI M FERRERO E FORTIS C GAJA G RUGARLI C
Citation: Me. Ferrero et al., LOCAL-REGIONAL IMMUNOTHERAPY OF PLEURAL TUMORS IN RATS, International journal of immunotherapy, 11(2), 1995, pp. 57-63

Authors: FORTIS C GALLI L CONSOGNO G CITTERIO G MATTEUCCI P SCAGLIETTI U BUCCI E
Citation: C. Fortis et al., SERUM LEVELS OF SOLUBLE CELL-ADHESION MOLECULES (ICAM-1, VCAM-1, E-SELECTIN) AND OF CYTOKINE TNF-ALPHA INCREASE DURING INTERLEUKIN-2 THERAPY, Clinical immunology and immunopathology, 76(2), 1995, pp. 142-147

Authors: BRAGA M DIFRANCESCO A GIANOTTI L VIGNALI A COSTANTINI E SOCCI C FORTIS C PAGANELLI G DICARLO V
Citation: M. Braga et al., THYMOPENTIN INCREASES THE SURVIVAL OF MICE AFTER ALLOGENEIC BLOOD-TRANSFUSION, BACTERIAL GAVAGE, AND BURN INJURY, The European journal of surgery, 160(6-7), 1994, pp. 345-350

Authors: BESANA C BORRI A BUCCI E CITTERIO G DILUCCA G FORTIS C MATTEUCCI P TOGNELLA S TRESOLDI M BAIOCCHI C LANDONIO G GHISLANDI E RUGARLI C
Citation: C. Besana et al., TREATMENT OF ADVANCED RENAL-CELL CANCER WITH SEQUENTIAL INTRAVENOUS RECOMBINANT INTERLEUKIN-2 AND SUBCUTANEOUS ALPHA-INTERFERON, European journal of cancer, 30A(9), 1994, pp. 1292-1298

Authors: CLEMENTI E BUCCI E CITTERIO G LANDONIO G CONSOGNO G FORTIS C
Citation: E. Clementi et al., REVERSIBLE ANERGY IN CIRCULATING LYMPHOCYTES OF CANCER-PATIENTS DURING INTERLEUKIN-2 THERAPY, Cancer immunology and immunotherapy, 39(3), 1994, pp. 167-171

Authors: MATTEUCCI P TRESOLDI M CHIESA G TOGNELLA S CITTERIO G FORTIS C BESANA C RUGARLI C
Citation: P. Matteucci et al., INTRAPLEURAL ADMINISTRATION OF INTERLEUKIN-2 AND LAK CELLS IN LOCALLYADVANCED NON-SMALL-CELL LUNG-CANCER - A CASE-REPORT, Tumori, 80(3), 1994, pp. 246-250

Authors: FORTIS C
Citation: C. Fortis, ROLE OF INTERLEUKIN-2 IN REGULATING LYMPHOCYTE-ACTIVATION AND RECIRCULATION (VOL 29A, PG 474, 1993), European journal of cancer, 29A(7), 1993, pp. 1074-1074
Risultati: 1-13 |